Literature DB >> 26391680

Stroke prevention following modified endoscopic ablation and appendectomy for atrial fibrillation.

Nan Ma1, Zhaolei Jiang1, Fei Chen1, Hang Yin1, Fangbao Ding1, Ju Mei2.   

Abstract

We reported the results of stroke prevention following modified endoscopic procedure for atrial fibrillation. 82 patients underwent modified endoscopic procedure for atrial fibrillation (AF), in whom 47 had paroxysmal, 28 had persistent, and 7 had long-standing atrial fibrillation. CHA2DS2VASC median score was 3 (range from 0 to 8). The procedure was performed on the beating heart, through 3 ports on the left chest wall. Pulmonary vein isolation and ablation of the left atrium were achieved by bipolar radiofrequency ablation. Left atrial appendage (LAA) was excluded by stapler. Brain CT, cardiac CT and 24-h Holter monitoring were performed following the procedure. The procedure was successfully completed for all patients. The mean duration was 122 ± 40.1 min. LAA was excluded after appendectomy and checked by intraoperative transesophageal echocardiography. The mean follow-up duration was 24.3 ± 3.5 months. No patients showed signs and symptoms of transient ischemic attack or stroke. No new positive findings were demonstrated by recurring brain CT scan performed after the procedure. Cardiac CT confirmed the absence of LAA and thrombosis in the left atrium. 87.8 % (72/82) of all patients were in sinus rhythm. Our results demonstrate that the modified endoscopic procedure is a safe, effective, and appropriate treatment for AF, which restores sinus rhythm and may be associated with the prevention of AF-related stroke.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Stroke; Surgery

Mesh:

Year:  2015        PMID: 26391680     DOI: 10.1007/s00380-015-0749-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  25 in total

1.  Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial.

Authors:  Maximilian Y Emmert; Gilbert Puippe; Stephan Baumüller; Hatem Alkadhi; Ulf Landmesser; Andre Plass; Dominique Bettex; Jacques Scherman; Jürg Grünenfelder; Michele Genoni; Volkmar Falk; Sacha P Salzberg
Journal:  Eur J Cardiothorac Surg       Date:  2013-05-08       Impact factor: 4.191

Review 2.  Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.

Authors:  Mark A Crandall; David J Bradley; Douglas L Packer; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

3.  Thoracoscopic stand-alone left atrial appendectomy for thromboembolism prevention in nonvalvular atrial fibrillation.

Authors:  Toshiya Ohtsuka; Mikio Ninomiya; Takahiro Nonaka; Motoyuki Hisagi; Takahiro Ota; Toru Mizutani
Journal:  J Am Coll Cardiol       Date:  2013-02-20       Impact factor: 24.094

4.  Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation.

Authors:  Eugene Patterson; Sunny S Po; Benjamin J Scherlag; Ralph Lazzara
Journal:  Heart Rhythm       Date:  2005-06       Impact factor: 6.343

Review 5.  Nonpharmacologic approaches to stroke prevention in atrial fibrillation.

Authors:  Richard P Whitlock; Hasib Hanif; Matthew Danter
Journal:  Can J Cardiol       Date:  2013-07       Impact factor: 5.223

6.  Warfarin use among patients with atrial fibrillation.

Authors:  L M Brass; H M Krumholz; J M Scinto; M Radford
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

7.  Efficacy and safety of novel epicardial circumferential left atrial ablation with pulmonary vein isolation in sustained atrial fibrillation.

Authors:  Zhaolei Jiang; Hang Yin; Yi He; Nan Ma; Min Tang; Hao Liu; Fangbao Ding; Ju Mei
Journal:  Heart Vessels       Date:  2014-10-17       Impact factor: 2.037

8.  Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Daniel E Singer; Gregory W Albers; James E Dalen; Margaret C Fang; Alan S Go; Jonathan L Halperin; Gregory Y H Lip; Warren J Manning
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 9.  Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?

Authors:  L K Gottlieb; S Salem-Schatz
Journal:  Arch Intern Med       Date:  1994-09-12

10.  Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation.

Authors:  Joseph L Blackshear; W Dudley Johnson; John A Odell; Vickie S Baker; Mary Howard; Lesly Pearce; Christopher Stone; Douglas L Packer; Hartzell V Schaff
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

View more
  2 in total

1.  Right minithoracotomy versus conventional median sternotomy for patients undergoing mitral valve surgery and Cox-maze IV ablation with entirely bipolar radiofrequency clamp.

Authors:  Zhaolei Jiang; Min Tang; Nan Ma; Hao Liu; Fangbao Ding; Chunrong Bao; Ju Mei
Journal:  Heart Vessels       Date:  2018-02-02       Impact factor: 2.037

2.  Cerebral oxygen desaturation in patients with totally thoracoscopic ablation for atrial fibrillation: A prospective observational study.

Authors:  Guohui Li; Liqiao Yang; Yuan Sun; Sai'e Shen
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.